oxcarbazepine has been researched along with Fibrillary Chorea in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Casasnovas, C; Castellano, A; Fons, C; Fourcade, S; Pujol, A; Ruiz, M; Schlüter, A; Verdura, E | 1 |
Hüfner, K; Linn, J; Strupp, M | 1 |
2 other study(ies) available for oxcarbazepine and Fibrillary Chorea
Article | Year |
---|---|
Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.
Topics: Ataxia; Channelopathies; Child; Child, Preschool; Dyskinesias; Epilepsy; Exome Sequencing; Female; Gene Expression Regulation; Homozygote; Humans; Infant; Infant, Newborn; Kv1.1 Potassium Channel; Male; Mutation; Myokymia; Oxcarbazepine; Pedigree | 2020 |
Recurrent attacks of vertigo with monocular oscillopsia.
Topics: Adult; Carbamazepine; Female; Humans; Myokymia; Oxcarbazepine; Recurrence; Vertigo; Vision Disorders | 2008 |